Overcoming undesirable hERG affinity by incorporating fluorine atoms: A case of MAO-B inhibitors derived from 1 H-pyrrolo-[3,2-c]quinolines.

Grychowska K, Olejarz-Maciej A, Blicharz K, Pietruś W, Karcz T, Kurczab R, Koczurkiewicz P, Doroz-Płonka A, Latacz G, Keeri AR, Piska K, Satała G, Pęgiel J, Trybała W, Jastrzębska-Więsek M, Bojarski AJ, Lamaty F, Partyka A, Walczak M, Krawczyk M, Malikowska-Racia N, Popik P, Zajdel P

Open source

DOI: 10.1016/j.ejmech.2022.114329
Published: 2022 Jun 5
Container: European journal of medicinal chemistry
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejmech.2022.114329,
  title = {Overcoming undesirable hERG affinity by incorporating fluorine atoms: A case of MAO-B inhibitors derived from 1 H-pyrrolo-[3,2-c]quinolines.},
  author = {Grychowska K and Olejarz-Maciej A and Blicharz K and Pietruś W and Karcz T and Kurczab R and Koczurkiewicz P and Doroz-Płonka A and Latacz G and Keeri AR and Piska K and Satała G and Pęgiel J and Trybała W and Jastrzębska-Więsek M and Bojarski AJ and Lamaty F and Partyka A and Walczak M and Krawczyk M and Malikowska-Racia N and Popik P and Zajdel P},
  year = {2022},
  journal = {European journal of medicinal chemistry},
  doi = {10.1016/j.ejmech.2022.114329},
  url = {https://doi.org/10.1016/j.ejmech.2022.114329}
}

RIS

TY  - JOUR
TI  - Overcoming undesirable hERG affinity by incorporating fluorine atoms: A case of MAO-B inhibitors derived from 1 H-pyrrolo-[3,2-c]quinolines.
AU  - Grychowska K
AU  - Olejarz-Maciej A
AU  - Blicharz K
AU  - Pietruś W
AU  - Karcz T
AU  - Kurczab R
AU  - Koczurkiewicz P
AU  - Doroz-Płonka A
AU  - Latacz G
AU  - Keeri AR
AU  - Piska K
AU  - Satała G
AU  - Pęgiel J
AU  - Trybała W
AU  - Jastrzębska-Więsek M
AU  - Bojarski AJ
AU  - Lamaty F
AU  - Partyka A
AU  - Walczak M
AU  - Krawczyk M
AU  - Malikowska-Racia N
AU  - Popik P
AU  - Zajdel P
PY  - 2022
JO  - European journal of medicinal chemistry
DO  - 10.1016/j.ejmech.2022.114329
UR  - https://doi.org/10.1016/j.ejmech.2022.114329
ER  -

APA

K, G., A, O., K, B., W, P., T, K., R, K., P, K., A, D., G, L., AR, K., K, P., G, S., J, P., W, T., M, J., AJ, B., F, L., A, P., M, W., M, K., N, M., P, P., & P, Z. (2022). Overcoming undesirable hERG affinity by incorporating fluorine atoms: A case of MAO-B inhibitors derived from 1 H-pyrrolo-[3,2-c]quinolines.. European journal of medicinal chemistry. https://doi.org/10.1016/j.ejmech.2022.114329

Source records

pubmed · retrieved 2026-09-26T12:06:59.245Z